Meta-analyses of FibroTest diagnostic value in chronic liver disease-Reference-Cited by-同舟云学术

Meta-analyses of FibroTest diagnostic value in chronic liver disease

Published:2007-10-15 Issue:1 Volume:7 Page:
ISSN:1471-230X
Container-title:BMC Gastroenterology
language:en
Short-container-title:BMC Gastroenterol

Author:

Poynard Thierry,Morra Rachel,Halfon Philippe,Castera Laurent,Ratziu Vlad,Imbert-Bismut Françoise,Naveau Sylvie,Thabut Dominique,Lebrec Didier,Zoulim Fabien,Bourliere Marc,Cacoub Patrice,Messous Djamila,Munteanu Mona,de Ledinghen Victor

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/article/10.1186/1471-230X-7-40/fulltext.html

Reference51 articles.

1. Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers RP, Thabut D, Ratziu V, Mercadier A, Benhamou Y, Hainque B: Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV-Fibrosure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol. 2004, 3: 8-10.1186/1476-5926-3-8.

2. Poynard T, Imbert-Bismut F, Munteanu M, Ratziu V: FibroTest-FibroSURE:towards a universal biomarker of liver fibrosis?. Expert Rev Mol Diag. 2005, 5: 15-21. 10.1586/14737159.5.1.15.

3. Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F, Messous D, Charlotte F, Di Martino V, Benhamou Y, Poynard T: Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol. 2003, 39: 222-230. 10.1016/S0168-8278(03)00171-5.

4. Poynard T, Zoulim F, Ratziu V, Degos F, Imbert-Bismut F, Deny P, Landais P, El Hasnaoui A, Slama A, Blin P, Thibault V, Parvaz P, Munteanu M, Trepo C: Longitudinal assessment of histology surrogate markers (Fibrotest-Actitest) during lamivudine therapy in patients with chronic hepatitis B infection. Am J Gast. 2005, 100: 1970-1980. 10.1111/j.1572-0241.2005.41957.x.

5. Naveau S, Raynard B, Ratziu V, Abella A, Imbert-Bismut F, Messous D, Beuzen F, Capron F, Thabut D, Munteanu M, Chaput JC, Poynard T: Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol Hepatol. 2005, 3: 167-174. 10.1016/S1542-3565(04)00625-1.

Cited by 261 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis;Hepatology;2024-03-15

2. Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients;Journal of Clinical Medicine;2024-02-12

3. The Diagnostic Value of FibroTest and Hepascore as Non-Invasive Markers of Liver Fibrosis in Primary Sclerosing Cholangitis (PSC);Journal of Clinical Medicine;2023-12-07

4. How to Identify Advanced Nonalcoholic Fatty Liver Disease in the Primary Care Setting;Seminars in Liver Disease;2023-05

5. The use of current knowledge and non‐invasive testing modalities for predicting at‐risk non‐alcoholic steatohepatitis and assessing fibrosis;Liver International;2023-03-27